Against this background, the aim of this study was to investigate our hypothesis that methylation of Uc160, Uc283, and Uc346 is associated with the transition of pre-malignant lesions to in situ, infiltrative, and metastatic tumors as well as with the clinical outcome of CRC patients. Here, RFX4-AS1 is linked to colorectal carcinoma.